IART

Integra Lifesciences Holding

-$214.5M

Net Activity

Institutions Holding

200

Popularity Rank

#2884

Avg Weight

0.05%

Total Value

$700.5M

Ownership Trend

200 institutions currently hold IART, with 91 net buyers and 105 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

105

Net Buying Institutions

91

Key Holders

View all 200 holding institutions

Quarterly Activity

Recent Activity

+$235.6M

Total Buy Value

$492.8M

Total Sell Value

New buy29
Trim69
Add62
Sold out36

91

Net Buyers

105

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding INTEGRA LIFESCIENCES HOLDING (IART)?
Major stakeholders currently include BlackRock, Inc. ($97.2M), Rubric Capital Management LP ($73.0M), Paradigm Capital Management Inc/ny ($37.8M). Based on the latest 13F filings, there are a total of 200 tracked investment funds and institutions maintaining positions in IART.
What is the overall institutional sentiment toward IART recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $214.5M, driven by 91 managers accumulating shares while 105 reduced their exposure.
Which institutions have been selling or reducing their IART positions?
In the latest period, 69 funds trimmed their holdings, and 36 managers completely exited their positions. The aggregate reported sell value was $492.8M.
Are there any notable investors adding IART to their portfolios?
Yes, buying activity remains notable. 29 institutions opened new positions in {ticker}, and 62 existing holders added to their shares. The total reported buy value for the quarter amounted to $235.6M.

Related Stocks